INFLAME-BANK is a French multicenter prospective observational ancillary study of the international EACVI-INFLAME project. It aims to establish a biobank and perform immunophenotyping and proteomic analyses in patients with suspected inflammatory cardiovascular diseases and autoimmune rheumatic diseases (ICARDs).
The primary objective is to identify immune biomarkers associated with cardiovascular prognosis and develop disease-specific prognostic scores to predict 1-year major adverse cardiovascular events (MACE). Secondary objectives include evaluating the diagnostic and prognostic value of immunoproteomic biomarkers, assessing the role of photon-counting CT (PCCT) imaging, and investigating immune signatures associated with genetic variants in acute myocarditis.
The study plans to enroll 300 patients from French centers participating in EACVI-INFLAME. Blood samples will be collected during routine clinical care at inclusion, with optional follow-up sampling at 12 months and optional PCCT imaging and genetic analyses depending on each center's participation. Patients will be followed for 12 months to monitor cardiovascular outcomes.
The expected impact is to improve understanding of the immune mechanisms underlying ICARDs, facilitate earlier diagnosis and risk stratification, identify new therapeutic targets, and ultimately support more personalized management of patients with inflammatory cardiovascular diseases.
Inclusion Criteria:
1. Patient enrolled in EACVI-INFLAME study 2. The patient consents
-
Exclusion Criteria:
Non-inclusion criteria (patients fulfilling any of the following criteria are not eligible for inclusion in this study):
1. Patients with a history of heart transplant 2. Patient unable to provide informed consent 3. Patient under complete or limited guardianship 4. Patient affected by pre-existing immunodeficiency, including HIV (not including immunosuppressive treatment)
-
theo.pezel@aphp.fr+33 6 68 72 24 89
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Deployment o the Multidisciplinary Prospective Cohort Imminent
Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN)
Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy. (ACORE)
Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases